DANIEL L. KISNER - 28 Jun 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
28 Jun 2023
Net transactions value
$0
Form type
4
Filing time
30 Jun 2023, 16:00:12 UTC
Previous filing
21 Jun 2023
Next filing
11 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCT Stock Options Award $0 +25,000 $0.000000 25,000 28 Jun 2023 Common Stock 25,000 $0.3553 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.